A randomised clinical trial on comparative efficacy of Nripvallabha Ghrita Nasya and Jalaukavacharana along with Pathyadi Ghana Vati orally in the management of Ardhavabhedaka w. s. r. to Migraine.

ational Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Patients willing to participate in this trial through written informed consent
•2. Patients presenting with symptoms of Ardhavabhedaka (migraine), described as per Ayurveda and modern science.

•1. Secondary headaches caused by meningitis, tumors, encephalitis, head and neck trauma, trigeminal neuralgia, cervical spondylitis, refractive errors, sinusitis and other disorders of cranium, neck, eyes, ears, nose, sinuses, teeth etc.
•2. Patients with complicated Migraine like status migrainosus, hemiplegic migraine and having any chronic debilitating disease with other neurological pathology.
•3. Pregnant and lactating women.
•4. Patients suffering from any other major systemic disorders e.g. tuberculosis, cancer, heart disease etc.
•5. Patients unfit for Jalaukavacharna such as patients with hemorrhagic diseases (e.g. hemophilia), anaemia, hypotension, severe allergic diathesis and on anticoagulant treatment.

发起方